Therapy Areas: Inflammatory Diseases
19 July 2019 - - US-based biopharmaceutical company Cortexyme, Inc. (NASDAQ: CRTX) has presented clinical data that supports its ongoing work to pioneer a novel, disease-modifying therapeutic approach...
19 July 2019 - PureTech Health, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut axis, has acquired and is planning to develop a clinical-stage...
18 July 2019 - - US-based biotechnology company Pandion Therapeutics, Inc has appointed Rahul Kakkar, MD, FACC as chief executive officer and as a member of the company's board of directors, the ...
18 July 2019 - - UK-based biopharmaceutical company PureTech Health plc (LSE: PRTC) has acquired and plans to develop a clinical-stage product candidate for the potential treatment of lymphatic and im...
18 July 2019 - Biopharmaceutical company Sosei Group Corporation (TSE:4565) reported on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for the Investigational New Dru...
17 July 2019 - - Canadian biopharmaceutical company Parvus Therapeutics has appointed Hugh Young Rienhoff, Jr., M.D., as chairman of the board, Charles A. Johnson, M.D., to the board of directors, and...
Related Headlines